United Nations selects INFARMED to analyze medicines for HIV / AIDS, tuberculosis and malaria -
The INFARMED laboratory has been selected worldwide to analyze medicines for the United Nations Development Program (UNDP) in the fight against HIV / AIDS, tuberculosis and malaria.
Under this contract, the INFARMED laboratory will continue to analyze medicines for the treatment of these diseases for existing UN offices worldwide, the National Drug Authority said.
One of the objectives of the United Nations Development Program, funded by the Global Fund, is to ensure access to quality, effective and safe medicines for people in countries where combating the three pandemics HIV / AIDS, malaria and tuberculosis is crucial.
In order to obtain support from this fund, those responsible for treatment programs in these areas must ensure that the medicinal products concerned meet the quality and safety requirements laid down by the United Nations, which are confirmed by analyzes carried out by this network of national laboratories.
The selection of the Directorate of Quality Assurance (QCD) between the laboratories recognized by the United Nations and the World Health Organization happens for the second time, confirming the technical competence of the INFARMED team.
Source: "Netfarma" website and author on November 2, 2016